Dr Reddy's Bids for Bradley Pharm -- CNBC

Includes: BDY, RDY
by: SA Eli Hoffmann

Dr Reddy's Laboratories Ltd. has submitted a preliminary bid for Bradley Pharmaceuticals, news channel CNBC-TV18 said Friday, citing unnamed sources. A spokesperson for Dr Reddy's declined to comment. On Aug. 9, Bradley said it had received preliminary bids for the company, but stopped short of naming bidders.

Sources: Dow Jones
Commentary: Bradley Pharmaceuticals: Reality Check, PleaseBradley Pharmaceuticals Shares Soar on Buyout Offer
Stocks/ETFs to watch: BDY, RDY

Seeking Alpha's news briefs are combined into a pre-market summary called Wall Street Breakfast. Get Wall Street Breakfast by email -- it's free and takes only seconds to sign up.